Important note: Information in this article was accurate in 2008. The state of the art may have changed since the publication date.
United Press International -- Dec. 30, 2008
The U.S. Food & Drug Administration approved the test from the Swiss firm Roche Diagnostics to screen donated blood for HIV-1 Group M RNA, hepatitis C RNA and hepatitis B DNA.
The test, called the cobas TaqScreen MPX Test for use on the cobas s 201 system, is a qualitative test for human plasma. The test, which is not intended for use as an aid in diagnosis, is designed to further increase the safety of blood supplies by identifying infections earlier than traditional serology tests -- identification of antibodies in the blood, statement from the drug company said.
"Roche is committed to meeting the needs of blood centers with tests and systems that ensure the highest blood safety," Daniel O'Day, head of Roche Molecular Diagnostics, the business area of Roche Diagnostics that developed the test, said in a statement.
"Our multiplex test has been widely adopted and has demonstrated excellent performance in blood centers worldwide."
081230
UP081220
Copyright © 2008 - United Press International. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through United Press International, Permissions Desk, 1510 H St. N.W. Washington DC 2005. Main Phone Switchboard: 202-898-8000 FAX: 202-898-8057 or 202-898-8147 Email: info@upi.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from the Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.
Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .